DONALD MCPHERSON: Open Payments
NPI 1215268586 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 14 payments from 7 companies in 2025. Trend: 2023 $436 · 2024 $407 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $104 |
| ABBVIE INC. | 2 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Indivior Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: CAPLYTA, HETLIOZ, UBRELVY, QULIPTA, SUBLOCADE, ABILIFY ASIMTUFII, XIFAXAN, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
